Monitoring of antiplatelet therapy with the PFA-100® in peripheral angioplasty patients

By Ziegler S.   Maca T.   Alt E.   Speiser W.   Schneider B.   Minar E.  

Platelets, Vol. 13, Iss. 8, 2002-12 ,pp. : 493-497

Informa Healthcare

Access to resources Recommend Favorite

Aspirin non-responsiveness as measured by PFA-100 in patients with coronary artery disease

By Andersen K.   Hurlen M.   Arnesen H.   Seljeflot I.  

Thrombosis Research, Vol. 108, Iss. 1, 2002-10 ,pp. : 37-42

Elsevier

Access to resources Recommend Favorite

Comparison of turbidimetric aggregation and in vitro bleeding time (PFA-100) for monitoring the platelet inhibitory profile of antiplatelet agents in patients undergoing stent implantation

By Van der Planken M.G.   Claeys M.J.   Vertessen F.J.   Dilling D.   Bosmans J.M.   Berneman Z.N.   Michiels J.J.   Vrints C.  

Thrombosis Research, Vol. 111, Iss. 3, 2003-01 ,pp. : 159-164

Elsevier

Access to resources Recommend Favorite

Incomplete inhibition of platelet function as assessed by the platelet function analyzer (PFA-100) identifies a subset of cardiovascular patients with high residual platelet response while on aspirin

By Crescente M.   Mezzasoma A. M.   Del Pinto M.   Palmerini F.   Di Castelnuovo A.   Cerletti C.   De Gaetano G.   Gresele P.  

Platelets, Vol. 22, Iss. 3, 2011-05 ,pp. : 179-187

Informa Healthcare

Access to resources Recommend Favorite

Lack of association between gene sequence variations of platelet membrane receptors and aspirin responsiveness detected by the PFA-100 system in patients with coronary artery disease

By Bernardo Esther   Angiolillo Dominick J.   Ramírez Celia   Cavallari Ugo   Trabetti Elisabetta   Sabaté Manel   Hernández Rosana   Moreno Raul   Escaned Javier   Alfonso Fernando   Bañuelos Camino   Costa Marco A.   Bass Theodore A.   Pignatti Pier Franco   Macaya Carlos   Fernandez-Ortiz Antonio  

Platelets, Vol. 17, Iss. 8, 2006-12 ,pp. : 586-590

Informa Healthcare

Access to resources Recommend Favorite